RT

Reji Thomas

Director Director DIN 03349922
DIN 03349922 First appointment Jan 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Reji Thomas

Data last updated:

Reji Thomas was a Director at Hitzelberger Life Sciences Private Limited (2011–2022) and Director at Dream Vascular Life Science Private Limited (from 2014). The companies operate in Pharma.

DIN 03349922
Primary Designation Director
Industry Pharma
First Appointment 19 Jan 2011
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20112011₹1.31 Cr (FY 2024)Active
Director01 Oct 20142013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dream Vascular Life Science Private Limited
Hitzelberger Life Sciences Private Limited
Premium access

Shareholding and investment profile for Reji Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reji Thomas

Reji Thomas was first appointed on 19 Jan 2011 as Director at Hitzelberger Life Sciences Private Limited. The most recent appointment on record is 01 Oct 2014 at Dream Vascular Life Science Private Limited.

Reji Thomas held 2 earlier board appointments: Hitzelberger Life Sciences Private Limited (Director, 19 Jan 2011 to 25 Aug 2022); Dream Vascular Life Science Private Limited (Director, from 01 Oct 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available